Libros importados hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
Take advantage of this pre-sale
portada Biosimilars Development Strategies: Fast to Market Approaches (in English)
Type
Physical Book
Publisher
Language
English
Pages
224
Format
Hardcover
ISBN13
9781032517018
Edition No.
1

Biosimilars Development Strategies: Fast to Market Approaches (in English)

Niazi Sarfaraz K. (Author) · Crc Press · Hardcover

Biosimilars Development Strategies: Fast to Market Approaches (in English) - Niazi Sarfaraz K.

Physical Book

$ 132.63

$ 140.00

You save: $ 7.37

5% discount
  • Condition: New
It will be shipped from our warehouse between Tuesday, July 30 and Thursday, August 01.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Biosimilars Development Strategies: Fast to Market Approaches (in English)"

After 18 years since the first biosimilar was approved, a lot has changed, from the regulatory guidelines to the stakeholder perceptions about the safety and efficacy of biosimilars. However, the development costs remain high, preventing faster entry into markets with more than 200 choices. Analyzing the regulatory filings of all approved biosimilars in the US and EU, a deep analysis of the scientific principles, and continuous challenges to the regulatory authorities have made it possible to plan the development on a fast track. This book teaches how to cut the current time and cost by more than 70%, based on the author's hands-on experience.Features: Describes the emergence of biosimilars since the first publication of the recombinant engineering patent, as well as a listing of all approved recombinant products, their patent expiry and their adoption across the globe. Provides a better understanding of the safety and efficacy of approved biosimilars. Global approval requires accommodating guidelines and detailed planning to avoid redundancy as well as high costs. The basic expectations of the agencies are presented here. Presents a detailed analysis of all EU and FDA-approved products with a comparative analysis. Renowned author and entrepreneur in the field of drug discovery and production.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews